|
Posaconazole-D4, 1.0 mg/mL,
|
P-108
|
1.0 mg/mL in Methanol
This stable-labeled
internal standard is suitable for quantification of posaconazole levels in
blood, serum, or plasma by HPLC or LC-MS/MS. Sold under the trade names Noxafil® and Posanol®, the antifungal posaconazole is used to treat invasive and systemic fungal infections. As a result of significant drug interactions, therapeutic drug monitoring of posaconazole is recommended when administered with protease inhibitors (PIs) or non-nucleoside reverse transcriptase inhibitors (NNRTIs).
|
|
|